On the morning of May 4, 2024, VINAVETCO held its Annual General Meeting of Shareholders (AGM) for 2024 on the 3rd Floor, Conference Hall, Vinavetco factory in Binh Luong Village Industrial Cluster, Tan Quang Commune, Van Lam District, Hung Yen Province. According to the regulations of Central Veterinary Medicine Joint Stock Company I, the contents of the AGM were approved with 100% of the total votes cast at the meeting.

The AGM was presided over by the Chairperson and members of the Board of Directors (BOD) for the term VI (2022 – 2027):

• • Mr. Nguyen Anh Tuan – Chairman of the Board of Directors – Chairperson of the Meeting
  • Mrs. Bui Huong Lien – Board Member
  • Mr. Nguyen Viet Hoang – Independent Board Member

At the General Meeting, the members of the Presidium, and the Head of the Vote Counting Committee, presented reports, proposals, and results of the items, specifically as follows:

1. Reports and Approval of Proposals:

1.1. Approval of Proposal No. 11-2024/TTr-ĐHĐCĐ dated April 2, 2024, regarding the Report on the Board of Directors’ Activities for 2023 and the Plan for 2024, with the voting results as follows: Total number of affirmative votes: 12,717,358 votes, accounting for 100% of the votes cast at the General Meeting.

Mr. Nguyen Anh Tuan – Chairman of the Board of Directors presented the Board’s activities report for 2023 and the direction for 2024.

1.2. The report on the activities of the Audit Committee for 2023 and the plan for the Audit Committee’s tasks in 2024: Approval of Proposal No. 12-2024/TTr-ĐHĐCĐ dated April 2, 2024, regarding the Audit Committee’s activity report for 2023 and the plan for the Audit Committee’s tasks in 2024. The voting results are as follows: Total votes in favor: 12,717,358 votes, accounting for 100% of the votes cast at the General Meeting.

Mr. Nguyen Viet Hoang – Independent Member of the Board of Directors presented the Audit Committee’s activity report for 2023 and the plan for the Audit Committee’s tasks in 2024.

• • Approved the report on the reviewed financial statements for the fiscal year from January 1, 2023, to December 31, 2023, of Central Veterinary Medicine Joint Stock Company I, prepared by UHY Audit and Consulting LLC, signed on March 28, 2024.
  • Approved the proposal for the profit distribution plan for 2023 and the plan for 2024.
  • Approved the proposal for the settlement of Board of Directors (BoD) and Audit Committee (AC) remuneration for 2023 and the proposed remuneration for BoD and AC members for 2024.
  • Approved the proposal for selecting the auditing firm for the year 2024.

2. Approved the change of members of the Board of Directors:

The Presidium presented commemorative flowers to the former and new members of the Board of Directors

During the discussion, the General Assembly acknowledged the heartfelt opinions and concerns of the shareholders regarding the company’s development in light of the current difficulties facing the industry. The encouragement and recognition of the efforts of the Company’s Management Board and the staff during Q4 of 2023 and from the beginning of 2024 to the present serve as a significant morale booster for Vinavetco to continue its ongoing innovation and comprehensive improvement.

Additionally, some major shareholders expressed their concerns and shared their questions, which were answered clearly and satisfactorily by the Presidium

.

Some images of shareholders sharing and contributing their opinions at the General Shareholders’ Meeting

The 2024 Annual General Shareholders’ Meeting of Central Veterinary Pharmaceutical Joint Stock Company I concluded successfully at 10:30 AM on the same day.

News: VINAVETCO